Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)

Contact us
Catalog number: SM-101050-10
Price: 426 €
Supplier: MBS Polyclonals_1
Product name: Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%)
Quantity: 50ug
Other quantities: 100 mg 913€
Related search:

More details :

ELISA kit stock availability: Available In Stock
ELISA's description: >, mol wt 468, 2, 3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, 98%), Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1
Category: Custom Service
S type: n/a
Antibody's host is: see techfile
Purification: Affinity purified
Description: Not all receptor antagonist that bind to enzymes are inhibitors, Since blocking an enzyme's activity can kill a pathogen , activator, caspase, esterase inhibitors , lipoprotein, many drugs are enzyme inhibitors, papain, pathway, peptidase, protease , proteinase, trypsin, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme,  , Tissue, acrosin, activity, and decreases its , are , bind to enzymes and increase their , enzymatic activity, enzyme activator ligands or agonists , enzyme receptor , imbalance, metabolic , or correct a , or receptor ligands or receptor antagonists that bind to an , proteins 
Gene target: >, mol wt 468, 2, 3-Triazol-1-yl)butyl)phenoxy)methyl) 2 (4-trifluoromethyl)oxazole, 98%, permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 (E) 4 (4 )1H-1
Short name: >, mol wt 468, 2, 3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, 98%), Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1
Alternative name: >, mol wt 468, 2, 3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, 98%), cellular permeable suppressor on EGFR2/FGFR/PDGFr/Janus kinase 1/Her2 ((E)-4-((4-)1H-1
Alternative to gene target: JAK1 and IDBG-638346 and ENSBTAG00000003147 and 537201, JAK1 and IDBG-99443 and ENSG00000162434 and 3716, JAK1A and JAK1B and JTK3, Jak1 and IDBG-167366 and ENSMUSG00000028530 and 16451, nuclei, this GO :0004672 and protein kinase activity and molecular function this GO :0004713 and protein tyrosine kinase activity and molecular function this GO :0004715 and non-membrane spanning protein tyrosine kinase activity and molecular function this GO :0005131 and growth hormone receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005524 and ATP binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0005856 and cytoskeleton and cellular component this GO :0006468 and protein phosphorylation and biological process this GO :0007167 and enzyme linked receptor protein signaling pathway and biological process this GO :0012505 and endomembrane system and cellular component this GO :0016020 and membrane and cellular component this GO :0016772 and transferase activity, this GO :0004672 : protein kinase activity, this GO :0004672 : protein kinase activity and also this GO :0004713 : protein tyrosine kinase activity and also this GO :0004715 : non-membrane spanning protein tyrosine kinase activity and also this GO :0005131 : growth hormone receptor binding and also this GO :0005515 : protein binding and also this GO :0005524 : ATP binding and also this GO :0016772 : transferase activity, this GO :0004713 : protein tyrosine kinase activity, this GO :0004715 : non-membrane spanning protein tyrosine kinase activity, this GO :0005131 : growth hormone receptor binding, this GO :0005515 : protein binding, this GO :0005524 : ATP binding, this GO :0016772 : transferase activity, this GO :0019903 : protein phosphatase binding, this GO :0031730 : CCR5 chemokine receptor binding, transferase activity, transferring phosphorus-containing groups, transferring phosphorus-containing groups and also this GO :0019903 : protein phosphatase binding and also this GO :0031730 : CCR5 chemokine receptor binding, transferring phosphorus-containing groups and molecular function this GO :0018108 and peptidyl-tyrosine phosphorylation and biological process this GO :0019221 and cytokine-mediated signaling pathway and biological process this GO :0019903 and protein phosphatase binding and molecular function this GO :0031730 and CCR5 chemokine receptor binding and molecular function this GO :0035556 and intracellular signal transduction and biological process this GO :0038110 and interleukin-2-mediated signaling pathway and biological process this GO :0045087 and innate immune response and biological process this GO :0046677 and response to antibiotic and biological process this GO :0046777 and protein autophosphorylation and biological process this GO :0060333 and interferon-gamma-mediated signaling pathway and biological process this GO :0060334 and regulation of interferon-gamma-mediated signaling pathway and biological process this GO :0060337 and type I interferon signaling pathway and biological process this GO :0060338 and regulation of type I interferon-mediated signaling pathway and biological process, Janus kinase 1
Identity: 6190
Gene: JAK1 | More about : JAK1
Long gene name: Janus kinase 1
Synonyms gene: JAK1B
Synonyms: JAK1A JTK3
Locus: 1p31, 3
Discovery year: 1992-04-16
GenBank acession: M64174
Entrez gene record: 3716
Pubmed identfication: 1848670 7698020
RefSeq identity: NM_002227
Classification: FERM domain containing
Havana BLAST/BLAT: OTTHUMG00000009310

Related Products :

SM-101050-10 Cell permeable Inhibitor of EGFR2/FGFR/PDGFr/JAK1/Her2 ((E)-4-((4-)1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-trifluoromethyl)oxazole, mol wt 468; >98%) 10 mg 188 € adi human
SM-101040-25 Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) 25 mg 623 € adi human
SM-101040-5 Cell permeable Inhibitor of EGFR/ERB family/Her2 (Neratinib/HKI-272, mol wt 557.04; >98%) 5 mg 188 € adi human
SM-101110-10 Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) 10 mg 159 € adi human
SM-101110-50 Mubritinib (TAK-165), potent Inhibitor of Her2/Erbb2 (IC50=6 nm; mol wt 468; >98%) 50 mg 449 € adi human
SM-101100-25 AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) 25 mg 1275 € adi human
SM-101100-5 AEE788 (NVP-AEE788), dual Inhibitor of Her2/Erbb2/EGFR (mol wt 440; >98%) 5 mg 260 € adi human
SM-101120-25 Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) 25 mg 1058 € adi human
SM-101120-5 Arry-380, Oral, potent Inhibitor of Her2/Erbb2 Tyr kinase (IC50=8 nM; mol wt 869; >98%) 5 mg 405 € adi human
SM-101090-25 AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) 25 mg 840 € adi human
SM-101090-5 AZD8931, reversible and competitive Inhibitor of Her2/Erbb2/ErbB3 (mol wt 473; >98%) 5 mg 333 € adi human
SM-101070-10 Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) 10 mg 159 € adi human
SM-101070-50 Canertinib (CI-1033), kinase Inhibitor of Her2/Erb2/EGFR (mol wt 485; >98%) 50 mg 405 € adi human
SM-101080-25 CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) 25 mg 623 € adi human
SM-101080-5 CP-724,714, Potent and selective Inhibitor of Her2/Erb2 (mol wt 469; >98%) 5 mg 188 € adi human
SM-101060-100 Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) 100 mg 333 € adi human
SM-101060-25 Lapatinib Ditosylate (GW572016, GW2016, Tykerb, Tyverb), Autophos. Inhibitor of Her2/Erb2 (mol wt 925; >98%) 25 mg 159 € adi human
SM-101030-100 Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) 100 mg 405 € adi human
SM-101030-25 Lapatinib, Inhibitor of Her2/EGFR (IC50=10 nM; mol wt 581; >98%) 25 mg 188 € adi human
SM-101130-25 Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) 25 mg 1058 € adi human
SM-101130-5 Tak-285, dual Inhibitor of Her2/EGFR Tyr kinase (IC50=17 nM; mol wt 547; >98%) 5 mg 405 € adi human
LFPI-4 Lethal factor protease Inhibitor-1, Cell permeable, 14aa MEK2 analog, competitive inhibitor of LF 1 mg 478 € adi human
SM-101010-5 Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) 5 mg 260 € adi human
SM-101010-50 Inhibitor of EGFR/HER family (Her1, Her2, Her3 or Pan Her-inhibitor) (BMS-59926/AC480, Mol wt 567.01, >99%) 50 mg 1203 € adi human
SM-101020-10 Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) 10 mg 188 € adi human
SM-101020-50 Inhibitor of EGFR/HDAC/Her2 (CUDC-101; 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide, Mol wt 434.49, >99%) 50 mg 623 € adi human
MBS622235 Fibroblast Growth Factor Receptor Substrate 3 (FRS3, FGFR Substrate 3, FGFR-signaling adaptor SNT2, Suc1-associated Neurotrophic Factor Target 2, SNT-2) Antibody 100ug 569 € MBS Polyclonals_1 human
MBS620116 JAK1 (Janus Kinase 1, JAK-1, JAK1A, JAK1B, JTK3, Tyrosine-protein Kinase JAK1) Antibody 100ug 542 € MBS Polyclonals_1 human
MBS623058 JAK1, phosphorylated (TYR1022/1023) (Janus kinase 1, JAK-1, JAK1A, JAK1B, JTK3, Tyrosine-protein Kinase JAK1) Antibody 100ul 619 € MBS Polyclonals_1 human
MBS624380 JAK1 (Tyrosine-protein Kinase JAK1, Janus Kinase 1, JAK-1, JAK1A, JAK1B) Antibody 50ug 426 € MBS Polyclonals_1 human